{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:18:53Z","timestamp":1788286733964,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The study sought to prospectively examine clinical, biochemical, and transmural outcomes. Transmural outcomes are assessed by ultrasound after 1 year in patients with inflammatory bowel disease (IBD) treated in line with standard of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The TRUST BEYOND study is a prospective, multicenter, noninterventional study at 49 sites in Germany, Austria, and Switzerland and includes 282 patients with IBD who have active disease at baseline. For this analysis, 163 patients with IBD (74 with Crohn\u2019s disease, 89 with ulcerative colitis) were followed up for 1 year. At baseline and at every 3\u2009months, clinical, biochemical, and ultrasound parameters, such as bowel wall thickness and color Doppler sonography, were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with IBD demonstrated vast improvements in clinical, biochemical, and ultrasound assessments as early as week 12. Rates of transmural response and healing progressively increased over the study period to up to 77.5% and 39.3%, respectively, in patients with ulcerative colitis and to 66.2% and 27.0%, respectively, in patients with Crohn\u2019s disease. Patients with early transmural response achieved numerically higher rates of various outcomes at week 52 than patients without early transmural response. In a multivariate analysis, transmural response at week 12 predicted clinical remission at week 52 (odds ratio, 4.3; 95% confidence interval, 2.45-7.52; P\u2009&amp;lt;\u2009.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that intestinal ultrasound is a suitable noninvasive modality to monitor patients with IBD in routine care. Transmural endpoints can be achieved in patients with IBD treated with standard of care and can predict outcomes after 1 year.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag074","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:36:53Z","timestamp":1775561813000},"page":"1770-1782","source":"Crossref","is-referenced-by-count":0,"title":["Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0183-4483","authenticated-orcid":false,"given":"Torsten","family":"Kucharzik","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Gastroenterology, University Teaching Hospital L\u00fcneburg , L\u00fcneburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-7633","authenticated-orcid":false,"given":"Ulf","family":"Helwig","sequence":"additional","affiliation":[{"name":"Gastroenterology Practice , Oldenburg,","place":["Germany"]},{"name":"University of Kiel , Kiel,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-054X","authenticated-orcid":false,"given":"Frank","family":"Seibold","sequence":"additional","affiliation":[{"name":"Crohn Colitis Centre , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-4125","authenticated-orcid":false,"given":"Luc","family":"Biedermann","sequence":"additional","affiliation":[{"name":"University Clinic Zurich , Zurich,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-0806","authenticated-orcid":false,"given":"Christoph","family":"H\u00f6genauer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz , Graz,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9582-6244","authenticated-orcid":false,"given":"Imma","family":"Fischer","sequence":"additional","affiliation":[{"name":"Biostatistics T\u00fcbingen , T\u00fcbingen,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-6337","authenticated-orcid":false,"given":"Leonie","family":"Hammer","sequence":"additional","affiliation":[{"name":"Medical Department, AbbVie Germany GmbH & Co. KG , Wiesbaden,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-0923","authenticated-orcid":false,"given":"Stefan","family":"Rath","sequence":"additional","affiliation":[{"name":"Medical Department, AbbVie Germany GmbH & Co. KG , Wiesbaden,","place":["Germany"]},{"name":"Center of Physiology, Pathophysiology and Biophysics, Paracelsus Medical University , Nuremberg, 90419,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-405X","authenticated-orcid":false,"given":"Christian","family":"Maaser","sequence":"additional","affiliation":[{"name":"Outpatients Department Gastroenterology, University Teaching Hospital L\u00fcneburg , L\u00fcneburg,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2026090114012066100_izag074-B1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"2026090114012066100_izag074-B2","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"2026090114012066100_izag074-B3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2020.03.039","article-title":"Deep remission at 1 year prevents progression of early Crohn\u2019s disease","volume":"159","author":"Ungaro","year":"2020","journal-title":"Gastroenterology"},{"key":"2026090114012066100_izag074-B4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","article-title":"Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis","volume":"14","author":"Shah","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026090114012066100_izag074-B5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cgh.2016.10.040","article-title":"Use of intestinal ultrasound to monitor Crohn\u2019s disease activity","volume":"15","author":"Kucharzik","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026090114012066100_izag074-B6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/gutjnl-2019-319451","article-title":"Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study","volume":"69","author":"Maaser","year":"2020","journal-title":"Gut"},{"key":"2026090114012066100_izag074-B7","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/apt.15013","article-title":"Persistent damage on magnetic resonance enterography in patients with Crohn\u2019s disease in endoscopic remission","volume":"48","author":"Rimola","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2026090114012066100_izag074-B8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1053\/j.gastro.2022.08.038","article-title":"Intestinal ultrasound is accurate to determine endoscopic response and remission in patients with moderate to severe ulcerative colitis: a longitudinal prospective cohort study","volume":"163","author":"de Voogd","year":"2022","journal-title":"Gastroenterology"},{"key":"2026090114012066100_izag074-B9","doi-asserted-by":"publisher","first-page":"17562848211006672","DOI":"10.1177\/17562848211006672","article-title":"Relevance of monitoring transmural disease activity in patients with Crohn\u2019s disease: current status and future perspectives","volume":"14","author":"Wilkens","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"key":"2026090114012066100_izag074-B10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00535-024-02077-z","article-title":"A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion","volume":"59","author":"Komatsu","year":"2024","journal-title":"J Gastroenterol"},{"key":"2026090114012066100_izag074-B11","doi-asserted-by":"publisher","first-page":"19jjaf033","DOI":"10.1093\/ecco-jcc\/jjaf033","article-title":"Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis-a Copenhagen IBD Cohort Study","volume":"19","author":"Madsen","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/apt.15190","article-title":"One-year clinical outcomes with biologics in Crohn\u2019s disease: transmural healing compared with mucosal or no healing","volume":"49","author":"Castiglione","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026090114012066100_izag074-B13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/apt.16892","article-title":"Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn\u2019s disease","volume":"56","author":"Vaughan","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026090114012066100_izag074-B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ueg2.12356","article-title":"Transmural remission improves clinical outcomes up to 5 years in Crohn\u2019s disease","volume":"11","author":"Fernandes","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"2026090114012066100_izag074-B15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/apt.16232","article-title":"Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn\u2019s disease","volume":"53","author":"Lafeuille","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2026090114012066100_izag074-B16","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.cgh.2019.10.042","article-title":"Response assessed by ultrasonography as target of biological treatment for Crohn\u2019s disease","volume":"18","author":"Zorzi","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026090114012066100_izag074-B17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/ecco-jcc\/jjac072","article-title":"Intestinal ultrasound early on in treatment follow-up predicts endoscopic response to anti-TNFalpha treatment in Crohn\u2019s disease","volume":"16","author":"de Voogd","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1053\/j.gastro.2025.06.002S0016-5085(25)00842-X","article-title":"Role of noninvasive imaging in the diagnosis and management of patients with suspected and established inflammatory bowel disease","volume":"169","author":"Kucharzik","year":"2025","journal-title":"Gastroenterology"},{"key":"2026090114012066100_izag074-B19","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1093\/jcag\/gwaa001","article-title":"Systematic review: patient perceptions of monitoring tools in inflammatory bowel disease","volume":"4","author":"Goodsall","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026090114012066100_izag074-B20","doi-asserted-by":"publisher","first-page":"jjaf106","DOI":"10.1093\/ecco-jcc\/jjaf106","article-title":"ECCO-ESGAR-ESP-IBUS guideline on diagnostics and monitoring of patients with inflammatory bowel disease: part 1","volume":"19","author":"Kucharzik","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cgh.2022.05.055","article-title":"Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn\u2019s disease","volume":"21","author":"Kucharzik","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026090114012066100_izag074-B22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ecco-jcc\/jjab173","article-title":"Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement","volume":"16","author":"Ilvemark","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/ecco-jcc\/jjab180","article-title":"ECCO-ESGAR topical review on optimizing reporting for cross-sectional imaging in inflammatory bowel disease","volume":"16","author":"Kucharzik","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B24","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/ibd\/izad274","article-title":"Early intestinal ultrasound predicts clinical and endoscopic treatment response and demonstrates drug-specific kinetics in moderate-to-severe ulcerative colitis","volume":"30","author":"de Voogd","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026090114012066100_izag074-B25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ueg2.12206","article-title":"Predictive value of Milan ultrasound criteria in ulcerative colitis: a prospective observational cohort study","volume":"10","author":"Allocca","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"2026090114012066100_izag074-B26","doi-asserted-by":"publisher","first-page":"1976-1986","DOI":"10.1093\/ecco-jcc\/jjae101","article-title":"Early intestinal ultrasound in severe ulcerative colitis identifies patients at increased risk of 1-year treatment failure and colectomy","author":"Ilvemark","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ecco-jcc\/jjaa151","article-title":"Point-of-care ultrasound in inflammatory bowel disease","volume":"15","author":"Allocca","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B28","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/ecco-jcc\/jjac083","article-title":"Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalised patients with severe ulcerative colitis","volume":"16","author":"Ilvemark","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ecco-jcc\/jjad152","article-title":"Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicentre prospective cohort study","volume":"18","author":"Piazza","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ecco-jcc\/jjab106","article-title":"Transmural response and transmural healing defined by intestinal ultrasound: new potential therapeutic targets?","volume":"16","author":"Helwig","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41575-021-00424-6","article-title":"Location is important: differentiation between ileal and colonic Crohn\u2019s disease","volume":"18","author":"Atreya","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026090114012066100_izag074-B32","doi-asserted-by":"crossref","first-page":"jjaf011","DOI":"10.1093\/ecco-jcc\/jjaf011","article-title":"Systematic review on definitions of intestinal ultrasound treatment response and remission in inflammatory bowel disease","volume":"19","author":"Allocca","year":"2025","journal-title":"J Crohns Colitis."},{"key":"2026090114012066100_izag074-B33","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/ecco-jcc\/jjad071","article-title":"Early intestinal ultrasound predicts long-term endoscopic response to biologics in ulcerative colitis","volume":"17","author":"Allocca","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026090114012066100_izag074-B34","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cgh.2024.12.030","article-title":"Intestinal ultrasound findings and their prognostic value in early Crohn\u2019s disease: a Copenhagen IBD cohort study","volume":"23","author":"Madsen","year":"2025","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/9\/1770\/68340522\/izag074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/9\/1770\/68340522\/izag074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:01:48Z","timestamp":1788285708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/9\/1770\/8687657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5,19]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag074","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,5,19]]}}}